Zinc plays a critical role in the cardioprotective effect of postconditioning by enhancing the activation of the RISK pathway in rat hearts

Journal of Molecular and Cellular Cardiology

Volumn 66, Issue , 2014, Pages 12-17

  Xu, Zhelong ^a,b   Kim, Seokjae ^c   Huh, Jin ^d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Chonnam National University   (South Korea)

^d Seoul National University Boramae Hospital   (South Korea)

Author keywords

Ischemic postconditioning; PP2A; The RISK pathway; Zinc

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE 1; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOTRANSFERASE; PROTEIN KINASE B; PROTEIN ZIP2; REPERFUSION INJURY SALVAGE KINASE; UNCLASSIFIED DRUG; ZINC; ZINC TRANSPORTER;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL LEVEL; CONTROLLED STUDY; CYTOSOL; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME PHOSPHORYLATION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; ISCHEMIC POSTCONDITIONING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

RATTUS;

ISCHEMIC POSTCONDITIONING; PP2A; THE RISK PATHWAY; ZINC;

ANIMALS; CARDIOTONIC AGENTS; CATION TRANSPORT PROTEINS; CATIONS, DIVALENT; CHELATING AGENTS; ETHYLENEDIAMINES; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; ISCHEMIC POSTCONDITIONING; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; ZINC;

EID: 84888230190     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.10.016     Document Type: Article

References (41)

1. Zhao Z.-Q., Corvera J.S., Halkos M.E., Kerendi F., Wang N.-P., Guyton R.A., et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol 2003, 285:H579-H588.
2. Yang X.M., Philipp S., Downey J.M., Cohen M.V. Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res Cardiol 2005, 100:57-63.
3. 2 receptors and mitochondrial KATP channels trigger cardiac postconditioning through redox signaling. Cardiovasc Res 2007, 75:168-177.
4. Zatta A.J., Kin H., Yoshishige D., Jiang R., Wang N., Reeves J.G., et al. Evidence that cardioprotection by postconditioning involves preservation of myocardial opioid content and selective opioid receptor activation. Am J Physiol 2008, 294:H1444-H1451.
5. Jang Y.G., Xi J.K., Wang H.H., Mueller R.A., Norfleet E.A., Xu Z.L. Postconditioning prevents reperfusion injury by activating delta-opioid receptors. Anesthesiology 2008, 108:243-250.
6. Yang X.-M., Proctor J.B., Cui L., Krieg T., Downey J.M., Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways. J Am Coll Cardiol 2004, 44:1103-1110.
7. Tsang A., Hausenloy D.J., Mocanu M.M., Yellon D.M. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res 2004, 95:230-232.
8. Gomez L., Paillard M., Thibault H., Derumeaux G., Ovize M. Inhibition of GSK3β by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion. Circulation 2008, 117:2761-2768.
9. Zatta A.J., Kin H., Lee G., Wang N., Jiang R., Lust R., et al. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling. Cardiovasc Res 2006, 70:315-324.
10. Hausenloy D.J., Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res 2004, 61:448-460.
11. Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., Ovize M. Postconditioning inhibits mitochondrial permeability transition. Circulation 2005, 111:194-197.
12. Bopassa J.-C., Ferrera R., Gateau-Roesch O., Couture-Lepetit E., Ovize M. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res 2006, 69:178-185.
13. Ovize M., Baxter G.F., Di Lisa F., Ferdinandy P., Garcia-Dorado D., Hausenloy D.J., et al. Postconditioning and protection from reperfusion injury: where do we standα Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res 2010, 87:406-423.
14. Barthel A., Ostrakhovitch E.A., Walter P.L., Kampkötter A., Klotz L.-O. Stimulation of phosphoinositide 3-kinase/Akt signaling by copper and zinc ions: mechanisms and consequences. Arch Biochem Biophys 2007, 463:175-182.
15. An W.-L., Pei J.-J., Nishimura T., Winblad B., Cowburn R.F. Zinc-induced anti-apoptotic effects in SH-SY5Y neuroblastoma cells via the extracellular signal-regulated kinase 1/2. Brain Res Mol Brain Res 2005, 135:40-47.
16. Ilouz R., Kaidanovich O., Gurwitz D., Eldar-Finkelman H. Inhibition of glycogen synthase kinase-3β by bivalent zinc ions: insight into the insulin-mimetic action of zinc. Biochem Biophys Res Commun 2002, 295:102-106.
17. Karagulova G., Yue Y., Moreyra A., Boutjdir M., Korichneva I. Protective role of intracellular zinc in myocardial ischemia/reperfusion is associated with preservation of protein kinase C isoforms. J Pharmacol Exp Ther 2007, 321:517-525.
18. McIntosh R., Lee S., Ghio A.J., Xi J., Zhu M., Shen X., et al. The critical role of intracellular zinc in adenosine A2 receptor activation induced cardioprotection against reperfusion injury. J Mol Cell Cardiol 2010, 49:41-47.
19. Deng Z., Dailey L., Soukup J., Stonehuerner J., Richards J., Callaghan K., et al. Zinc transport by respiratory epithelial cells and interaction with iron homeostasis. Biometals 2009, 22:803-815.
20. Mykytenko J., Reeves J., Kin H., Wang N.-P., Zatta A., Jiang R., et al. Persistent beneficial effect of postconditioning against infarct size: role of mitochondrial KATP channels during reperfusion. Basic Res Cardiol 2008, 103:472-484.
21. Berg J.M., Shi Y. The galvanization of biology: a growing appreciation for the roles of zinc. Science 1996, 271:1081-1085.
22. Little P.J., Bhattacharya R., Moreyra A.E., Korichneva I.L. Zinc and cardiovascular disease. Nutrition 2010, 26:1050-1057.
23. Viswanath K., Bodiga S., Balogun V., Zhang A., Bodiga V. Cardioprotective effect of zinc requires ErbB2 and Akt during hypoxia/reoxygenation. Biometals 2011, 24:171-180.
24. Kasi V., Bodiga S., Kommuguri U.N., Sankuru S., Bodiga V.L. Zinc pyrithione salvages reperfusion injury by inhibiting NADPH oxidase activation in cardiomyocytes. Biochem Biophys Res Commun 2011, 410:270-275.
25. Lee S., Chanoit G., McIntosh R., Zvara D.A., Xu Z.L. Molecular mechanism underlying Akt activation in zinc-induced cardioprotection. Am J Physiol 2009, 297:H569-H575.
26. Chanoit G., Lee S., Xi J., Zhu M., McIntosh R.A., Mueller R.A., et al. Exogenous zinc protects cardiac cells from reperfusion injury by targeting mitochondrial permeability transition pore through inactivation of glycogen synthase kinase-3β. Am J Physiol 2008, 295:H1227-H1233.
27. Liuzzi J.P., Cousins R.J. Mammalian zinc transporters. Annu Rev Nutr 2004, 24:151-172.
28. Lichten L.A., Cousins R.J. Mammalian zinc transporters: nutritional and physiologic regulation. Annu Rev Nutr 2009, 29:153-176.
29. Taylor K.M., Hiscox S., Nicholson R.I., Hogstrand C., Kille P. Protein kinase CK2 triggers cytosolic zinc signaling pathways by phosphorylation of zinc channel ZIP7. Sci Signal 2012, 5. [ra11-].
30. Hausenloy D., Yellon D. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev 2007, 12:217-234.
31. Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking, and signals. J Biol Chem 2006, 281:24085-24089.
32. Mocchegiani E., Giacconi R., Malavolta M. Zinc signalling and subcellular distribution: emerging targets in type 2 diabetes. Trends Mol Med 2008, 14:419-428.
33. 2+ via cGMP/PKG signaling pathway and prevents mitochondrial oxidant damage in cardiomyocytes. Cardiovasc Res 2007, 75:426-433.
34. Csermely P., Szamel M., Resch K., Somogyi J. Zinc can increase the activity of protein kinase C and contributes to its binding to plasma membranes in T lymphocytes. J Biol Chem 1988, 263:6487-6490.
35. Huang J.-S., Mukherjee J.J., Chung T., Crilly K.S., Kiss Z. Extracellular calcium stimulates DNA synthesis in synergism with zinc, insulin and insulin-like growth factor I in fibroblasts. Eur J Biochem 1999, 266:943-951.
36. Brautigan D.L., Bornstein P., Gallis B. Phosphotyrosyl-protein phosphatase. Specific inhibition by Zn. J Biol Chem 1981, 256:6519-6522.
37. Haase H., Maret W. Intracellular zinc fluctuations modulate protein tyrosine phosphatase activity in insulin/insulin-like growth factor-1 signaling. Exp Cell Res 2003, 291:289-298.
38. Weinbrenner C., Baines C.P., Liu G.-S., Armstrong S.C., Ganote C.E., Walsh A.H., et al. Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia. Circulation 1998, 98:899-905.
39. Armstrong S.C., Ganote C.E. Effects of the protein phosphatase inhibitors okadaic acid and calyculin A on metabolically inhibited and ischaemic isolated myocytes. J Mol Cell Cardiol 1992, 24:869-884.
40. Powell S.R. The antioxidant properties of zinc. J Nutr 2000, 130:1447S-1454S.
41. 2+ overload. Am J Physiol 2005, 288:H1900-H1908.